Personalized Brain Cancer Vaccine May Help Against Aggressive Glioblastoma
discovermagazine - Discover how a personalized DNA vaccine trained patients’ immune systems to target their own tumors, with one participant remaining cancer-free nearly five years later.
AI Summary: A customized vaccine targeting each patient's tumor has demonstrated encouraging immune responses and signs of clinical benefit against aggressive glioblastoma. Researchers report enhanced T‑cell activity and preliminary survival signals, suggesting personalized neoantigen vaccines may help control this stubborn brain cancer and warrant larger, controlled trials to confirm impact.
- New models and datasets speeding brain tumor research (3)
- Next-gen glioblastoma immunotherapies: CAR T, drugs, stem cells (3)
- Personalized glioblastoma vaccine: early immune and survival signals (3)
- All Other Stories
New models and datasets speeding brain tumor research
Next-gen glioblastoma immunotherapies: CAR T, drugs, stem cells
Personalized glioblastoma vaccine: early immune and survival signals
All Other Stories
Related Stories
Enhertu (DESTINY‑Lung04) improves PFS in HER2‑mutant lung cancer / 6 days
Engineered bacteria show promise as tumor‑targeting therapy in preclinical studies / 5 wks
Daraxonrasib shows encouraging activity in NRAS-driven melanoma patients / 6 wks
First‑in‑human glioblastoma immunotherapy yields promising PFS benefit / 7 wks
Rogaratinib shows activity in SDH‑deficient GIST phase 2 trial / 3 months
Genetic clues explain tagraxofusp resistance in rare leukemia (BPDCN) / 7 wks
Adjuvant selpercatinib sharply cuts recurrence in RET‑fusion lung cancer / 2 months
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Venture Capital, Nutrition, Public Health, Zoonotic Disease and look for the RSS link.
StackHealth Time Machine